FDA is currently reviewing Tzield for use in patients eight years and over recently diagnosed with stage 3 T1D to prevent the progression of diseaseFDA is currently reviewing Tzield for use in patients eight years and over recently diagnosed with stage 3 T1D to prevent the progression of disease
Sanofi’s Tzield receives FDA approval to treat Type 1 diabetes in children